Rayonier Advanced Materials
RYAM · NYSE
About RYAM
- Employees
- 2,325
- Headquarters
- Jacksonville, Florida
- Listed
- Jun 16, 2014
- Sector
- Materials
- Industry
- Chemicals
- Website
- ryam.com
RYAM key statistics
- Market cap
- 473.51M
- Price-earnings ratio
- 0.00
- Dividend yield
- —
- Average volume
- 925.22K
- Volume
- 535.60K
- Open price
- $6.89
- High today
- $7.12
- Low today
- $6.88
- 52 Week high
- $11.85
- 52 Week low
- $5.38
Rayonier Advanced Materials (RYAM) at a glance
Rayonier Advanced Materials (RYAM) last traded at $7.00, with a market cap of 473.51M and a price-to-earnings ratio of 0.00.
Today the stock has traded between $6.88 and $7.12. The current price is 1.7% above the day's low and 1.7% below its high.
Volume so far is 535.60K shares, below the average of 925.22K shares a day.
Over the past year Rayonier Advanced Materials has ranged from $5.38 to $11.85, and now sits 25% of the way up that range.
Rayonier Advanced Materials met or beat analyst EPS estimates in 1 of the last 8 quarters. In Q2 FY26 it reported -$0.49 per share against an estimate of -$0.2278.
The average analyst price target is $14.28, 104.0% above the current price, from 1 recent ratings.
Analyst ratings
Latest rating from each analyst over the past 12 months
- Buy100.0%
- Hold0.0%
- Sell0.0%
- Low
- $13.13
- Now
- $7.00
- High
- $15.75
RYAM earnings
Earnings per share, reported against the analyst estimate
Beat the estimate in 1 of the last 8 quarters, by 47.5% on average.
- Q3 FY24: reported -$0.12 per share against an estimate of -$0.0782
- Q4 FY24: reported -$0.10 per share against an estimate of -$0.1904
- Q1 FY25: reported -$0.49 per share against an estimate of -$0.0544
- Q2 FY25: reported -$5.47 per share against an estimate of -$0.238
- Q3 FY25: reported -$0.07 per share against an estimate of -$0.017
- Q4 FY25: reported -$0.30 per share against an estimate of -$0.0816
- Q1 FY26: reported -$1.22 per share against an estimate of -$0.3638
- Q2 FY26: reported -$0.49 per share against an estimate of -$0.2278
RYAM news
- Press releaseBusiness Wire
- Press releaseBusiness Wire
RYAM Reports Second Quarter 2026 Results
- Press releaseBusiness Wire
RYAM Schedules Second Quarter 2026 Earnings Release
- Caroline Ryan
Deal Dispatch: Penske Buys Vox Media's Digital Brands, AbbVie Acquires Apogee Therapeutics For $10.9 Billion, Camp Mystic Bankruptcy
- Press releaseBusiness Wire
Rayonier Advanced Materials Completes Previously Announced Employment Inducement Award for President and Chief Executive Officer
- Press releaseBusiness Wire
Rayonier Advanced Materials Announces the Appointment of Daniel M. Krawczyk as Chief Executive Officer; Company Continues Comprehensive Review of Strategic Alternatives
- Press releasePRNewswire
MILL POND CAPITAL URGES SALE OF RAYONIER ADVANCED MATERIALS
- Press releaseBusiness Wire
Rayonier Advanced Materials Board of Directors Elects Julie A. Dill as Non-Executive Chair
Similar companies
Companies in the same industry as Rayonier Advanced Materials
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0003−16.67%
- SEIISharing Economy International$0.0004+100.00%
- NWGLCL Workshop Group$0.1522+27.90%
- TMSHTrans Global Assets$0.0002+0.00%
- AEFIAmerican EcoFuels$0.0007+0.00%
- CBDW1606$0.0002+0.00%
- FITYFifty 1 Labs$0.0001−66.67%
- PRSOPeraso$0.5914+54.13%
- SDSTStardust Power$0.02−23.66%
- SHFSSHF Holdings$0.0899−4.36%
- FRTTFort Technology$0.7121+32.63%
- CBDLCBD Life Sciences$0.0002−25.00%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.56+1.54%
- CTYCITY THERAPEUTICS$20.83−2.94%
- IAMIambic Therapeutics$16.01−2.02%
- AMROAmaero$5.68+1.25%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.28−0.10%
- TRXBTRex Bio$14.44−2.43%
- RTSNRetension Pharmaceuticals$16.18−0.92%
- PAXGUPine Tree Acquisition$9.98+0.00%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.18+3.39%
- ACCVAccelevation Holdings$12.31−1.44%
- RZAIROZE AI$10.28+1.28%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.